Traws Pharma, Inc. · NASDAQ:TRAW
Squadron Capital Management LLC's stake in Traws Pharma, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Squadron Capital Management LLC's stake in Traws Pharma, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squadron Master Fund LP | 0% | 0 |
| Squadron Capital Management LLC | 0% | 0 |
| Matthew Sesterhenn | 0% | 0 |
| William Blank | 0% | 0 |
Source
Related
- Traws Pharma, Inc.
- Squadron Capital Management LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Feb 17, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Nov 14, 2025
- Schedule 13G · Squadron Capital Management LLC · Sep 19, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13D/A · Orbimed Advisors LLC · May 5, 2026